# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-091823
Filing Date
2024-08-06
Accepted
2024-08-06 16:13:30
Documents
64
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | idya-20240630.htm iXBRL | 10-Q | 1700148
2 | EX-31.1 | idya-ex31_1.htm | EX-31.1 | 15385
3 | EX-31.2 | idya-ex31_2.htm | EX-31.2 | 15050
4 | EX-32.1 | idya-ex32_1.htm | EX-32.1 | 12436
| Complete submission text file | 0000950170-24-091823.txt |  | 7254787

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | idya-20240630.xsd | EX-101.SCH | 1158966
66 | EXTRACTED XBRL INSTANCE DOCUMENT | idya-20240630_htm.xml | XML | 1087518

Mailing Address 7000 SHORELINE CT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE CT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

EIN.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38915 | Film No.: 241179401
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)